TradingAgents AISign inGet started
All stock profiles
NXTCNASDAQHealthcare

NEXTCURE INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$6.31

-3.29%

Alpha Vantage · 10/30/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 0 recent
Analyze NXTC free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

+27.2%

3 months

+43.4%

6 months

-32.6%

1 year

-48.5%

Year to date

-55.5%

52-week range

$1.60 – $14.27

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$28.9M

P/E

-0.7

P/B

2.4

P/S

—

Revenue

$0

Net income

-$42.75M

Diluted EPS

-8.7

Gross margin

—

Net margin

—

Return on equity

-175.50%

Total debt

$3.6M

Cash

$15.26M

Free cash flow

-$36.98M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026$0-$14.89M——-$9.72M
Mar 31, 2026$0-$9.8M——-$13.36M
Dec 31, 2025$0-$9.44M——-$7.64M
Sep 30, 2025$0-$8.62M——-$6.27M
Jun 30, 2025$0-$26.81M——-$22.71M
Mar 31, 2025$0-$10.98M——-$12.99M
Dec 31, 2024$0-$11.6M——-$6.94M
Sep 30, 2024$0-$11.54M——-$11.62M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent NXTC news

All market news

No ticker-linked stories are in the current archive.